Page last updated: 2024-10-29

iopromide and Delayed Hypersensitivity

iopromide has been researched along with Delayed Hypersensitivity in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research Excerpts

ExcerptRelevanceReference
"To prospectively evaluate adverse events (AEs) in patients who underwent nonionic monomeric or dimeric contrast media-enhanced computed tomography (CT) and to compare these effects with AEs in patients who underwent unenhanced CT."2.72Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. ( Böhm, I; Hübner-Steiner, U; Kuhl, CK; Schild, HH; Speck, U, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schild, HH1
Kuhl, CK1
Hübner-Steiner, U1
Böhm, I1
Speck, U1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective Clinical Trial to Investigate Adverse Reactions to MR and CT-examinations (Enhanced and Unenhanced)[NCT01132339]1,467 participants (Actual)Observational2010-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for iopromide and Delayed Hypersensitivity

ArticleYear
Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.
    Radiology, 2006, Volume: 240, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Hypersensitivity, Delayed; Iohexol;

2006